Your browser doesn't support javascript.
loading
Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".
Pang, Jing; Chan, Dick C; Hu, Miao; Muir, Lauretta A; Kwok, See; Charng, Min-Ji; Florkowski, Christopher M; George, Peter M; Lin, Jie; Loi, Do Doan; Marais, A David; Nawawi, Hapizah M; Gonzalez-Santos, Lourdes E; Su, Ta-Chen; Truong, Thanh Huong; Santos, Raul D; Soran, Handrean; Tomlinson, Brian; Yamashita, Shizuya; Ademi, Zanfina; Watts, Gerald F.
Afiliação
  • Pang J; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
  • Chan DC; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
  • Hu M; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR.
  • Muir LA; Biochemistry and Pathology, Canterbury Health Laboratories, Lipid Clinic, Christchurch Hospital, University of Otago, Christchurch, New Zealand.
  • Kwok S; University of Manchester, Faculty of Biology, Medicine and Health, Manchester, United Kingdom; Cardiovascular Trials Unit, Clinical Trial Management Office, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Charng MJ; Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Florkowski CM; Biochemistry and Pathology, Canterbury Health Laboratories, Lipid Clinic, Christchurch Hospital, University of Otago, Christchurch, New Zealand.
  • George PM; Biochemistry and Pathology, Canterbury Health Laboratories, Lipid Clinic, Christchurch Hospital, University of Otago, Christchurch, New Zealand.
  • Lin J; Department of Atherosclerosis, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
  • Loi DD; Department of Cardiology, Hanoi Medical University, Hanoi, Vietnam; Vietnam National Heart Institute, Bach Mai Hospital, Hanoi, Vietnam.
  • Marais AD; Division of Chemical Pathology, University of Cape Town Health Science Faculty, South Africa.
  • Nawawi HM; Institute of Pathology, Laboratory and Forensic Medicine (I-PPerForM), Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia.
  • Gonzalez-Santos LE; Department of Cardiology, Section of Preventive Cardiology, UP-Philippine General Hospital, Manila, Philippines.
  • Su TC; Departments of Environmental and Occupational Medicine, Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Truong TH; Department of Cardiology, Hanoi Medical University, Hanoi, Vietnam; Vietnam National Heart Institute, Bach Mai Hospital, Hanoi, Vietnam.
  • Santos RD; Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital and Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Soran H; University of Manchester, Faculty of Biology, Medicine and Health, Manchester, United Kingdom; Cardiovascular Trials Unit, Clinical Trial Management Office, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Tomlinson B; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR.
  • Yamashita S; Departments of Cardiovascular Medicine and Community Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Rinku General Medical Center, Osaka, Japan.
  • Ademi Z; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Watts GF; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Department of Cardiology, Lipid Disorders Clinic, Cardiometabolic Services, Royal Perth Hospital, Perth, Western Australia, Australia. Electronic address: gerald.watts@uw
J Clin Lipidol ; 13(2): 287-300, 2019.
Article em En | MEDLINE | ID: mdl-30797720

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção à Saúde / Hiperlipoproteinemia Tipo II Tipo de estudo: Etiology_studies / Guideline / Health_technology_assessment / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção à Saúde / Hiperlipoproteinemia Tipo II Tipo de estudo: Etiology_studies / Guideline / Health_technology_assessment / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article